Tulsa Wealth Advisors’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$489K Buy
7,264
+567
+8% +$37.8K 0.07% 110
2026
Q1
$421K Buy
6,697
+217
+3% +$15.1K 0.07% 110
2025
Q4
$430K Buy
+6,480
New +$419K 0.14% 79

Other funds holding DXCM

Tulsa Wealth Advisors's DXCM Position: Q2 2026 in Review

Tulsa Wealth Advisors increased its DexCom (DXCM) stake by 8.5% in Q2 2026, buying an estimated $37.8K and bringing the position to 7,264 shares worth $489K. The position accounts for 0.07% of the portfolio, ranked #110.

Tulsa Wealth Advisors first reported a position in DXCM in Q4 2025 and has held it in 3 quarters since. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Tulsa Wealth Advisors held 7,264 shares of DexCom worth $489K as of Q2 2026.
  • Tulsa Wealth Advisors bought 567 DexCom shares in Q2 2026, an estimated $37.8K.
  • DexCom made up 0.07% of Tulsa Wealth Advisors's portfolio in Q2 2026, its #110 holding.
  • Tulsa Wealth Advisors first reported a position in DexCom in Q4 2025 and has held it in 3 quarters since.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Tulsa Wealth Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.